Skip to main content

Table 4 Five-year disease-specific survival for rectal cancer patients according to time period (95% CIa)

From: Long-term survival among colorectal cancer patients in Finland, 1991–2015: a nationwide population-based registry study

Time period

FCRb class 0

FCR class 1

FCR class 2

FCR class 3

FCR class 4

FCR class 5

FCR class 6

1991–1995

53.2 (48.9–57.5)

69.4 (67.0–71.8)

44.0 (38.7–49.3)

12.2 (9.8–14.6)

14.9 (7.8–22.0)

NAc

NA

1996–2000

58.3 (55.0–61.6)

78.0 (75.8–80.2)

47.2 (42.9–51.5)

13.6 (11.2–16.0)

14.9 (7.5–22.3)

NA

NA

2001–2005

56.7 (53.0–60.4)

83.1 (81.1–85.1)

65.8 (61.9–69.7)

18.5 (16.0–21.0)

33.7 (27.4–40.0)

87.9 (82.8–93.0)

10.3 (4.0–16.6)

2006–2010

52.5 (48.1–56.8)

88.5 (86.7–90.3)

67.8 (64.1–71.5)

44.4 (41.7–47.1)

41.8 (32.3–50.8)

79.2 (75.7–82.7)

17.6 (13.1–22.1)

2011–2015

63.6 (60.5–66.7)

90.5 (87.8–93.2)

68.9 (64.6–73.2)

38.6 (33.3–43.9)

55.5 (48.6–62.4)

75.7 (70.8–80.6)

15.3 (11.0–19.6)

  1. Abbreviations: aConfidence interval. bFinnish Cancer Registry. 0) Unknown, 1) localised, 2) nonlocalised with only regional lymph node metastases, 3) metastasised further than to regional lymph nodes or invasion to adjacent tissues, 4) nonlocalised with no information on extent, 5) locally advanced with the tumour invading adjacent tissues and 6) nonlocalised with distant lymph node metastases as well. cNot applicable